Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ · Healthcare
$116.62-1.88%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $6.44B
- P/E ratio
- —
- EPS
- —
- Volume
- 327,367
- 52-week high
- —
- 52-week low
- —
- Open
- $118.95
- Day high
- $120.54
- Day low
- $116.12
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $521.31M | -$23.36M | -$0.47 |
| 2024 | $336.89M | -$87.94M | -$1.85 |
| 2023 | $186.37M | -$163.42M | -$4.00 |
| 2022 | $77.06M | -$135.67M | -$4.02 |
| 2021 | $19.14M | -$83.99M | -$2.77 |
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
- CEO
- Christopher Peetz
- Employees
- 418
- Country
- US
- IPO date
- Jul 18, 2019
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Mirum Pharmaceuticals, Inc.'s stock price today?
- MIRM is trading at $116.62 as of Jul 20, 2026.
- What is Mirum Pharmaceuticals, Inc.'s market cap?
- Mirum Pharmaceuticals, Inc. (MIRM) has a market capitalization of $6.44B.
- Does Mirum Pharmaceuticals, Inc. pay a dividend?
- Mirum Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Mirum Pharmaceuticals, Inc. in?
- Mirum Pharmaceuticals, Inc. operates in the Healthcare sector.